| Literature DB >> 27747244 |
Guoxin Fan1, Xinbo Wu1, Shunzhi Yu1, Qi Sun1, Xiaofei Guan1, Hailong Zhang1, Xin Gu1, Shisheng He1.
Abstract
The aim of this study was to directly compare the clinical outcomes of posterior lumbar interbody fusion (PLIF) and minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) in three-level lumbar spinal stenosis. This retrospective study involved a total of 60 patients with three-level degenerative lumbar spinal stenosis who underwent MIS-TLIF or PLIF from January 2010 to February 2012. Back and leg visual analog scale (VAS), Oswestry Disability Index (ODI), and Short Form-36 (SF-36) scale were used to assess the pain, disability, and health status before surgery and postoperatively. In addition, the operating time, estimated blood loss, and hospital stay were also recorded. There were no significant differences in back VAS, leg VAS, ODI, SF-36, fusion condition, and complications at 12-month follow-up between the two groups (P > 0.05). However, significantly less blood loss and shorter hospital stay were observed in MIS-TLIF group (P < 0.05). Moreover, patients undergoing MIS-TLIF had significantly lower back VAS than those in PLIF group at 6-month follow-up (P < 0.05). Compared with PLIF, MIS-TLIF might be a prior option because of noninferior efficacy as well as merits of less blood loss and quicker recovery in treating three-level lumbar spinal stenosis.Entities:
Mesh:
Year: 2016 PMID: 27747244 PMCID: PMC5056235 DOI: 10.1155/2016/9540298
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Surgical procedure of minimally invasive transforaminal lumbar interbody fusion. (a) Preoperative location with our self-made locator; (b) skin marker with the assistance of our self-made locator; (c) cage placement; (d) mark for screw placement; (e) lateral fluoroscopy of screw placement; (f) anteroposterior fluoroscopy of pedicle screw placement.
Figure 2Minimally invasive transforaminal lumbar interbody fusion versus posterior lumbar interbody fusion in three-level spinal stenosis. (a) Preoperative magnetic resonance imaging; (b) anteroposterior fluoroscopy of three-level minimally invasive transforaminal lumbar interbody fusion; (c) lateral fluoroscopy of minimally invasive transforaminal lumbar interbody fusion; (d) minimal incision and skin healing of minimally invasive transforaminal lumbar interbody fusion; (e) lateral fluoroscopy of three-level posterior lumbar interbody fusion; (f) anteroposterior fluoroscopy of three-level posterior lumbar interbody fusion.
Clinical characteristics of included patients with three-level spinal stenosis.
| Variables | PLIF | MIS-TLIF |
|
|---|---|---|---|
| Age | 64.4 | 65.9 | 0.387 |
| Gender | |||
| Male | 17 | 14 | 0.4 |
| Female | 19 | 10 | |
| Lesion segments | |||
| L1–4 | 8 | 6 | 0.96 |
| L2–5 | 16 | 10 | |
| L3-S1 | 12 | 8 | |
| Fusion + fixation | |||
| Single-segmental fusion + three-segmental fixation | 13 | 7 | 0.75 |
| Two-segmental fusion + three-segmental fixation | 9 | 8 | |
| Three-segmental fusion + three-segmental fixation | 14 | 9 | |
| Follow-up | 13.4 | 14.2 | 0.58 |
Clinical outcomes of PLIF versus MIS-TLIF in three-level spinal stenosis.
| Parameters | PLIF ( | MIS-TLIF ( |
|
|---|---|---|---|
| Operation time (min) | 227.5 ± 17.1 | 270.8 ± 33.7 | 0.01 |
| Blood loss (mL) | 908.3 ± 242.9 | 666.7 ± 314.3 | 0.04 |
| Hospital stay | 15.5 ± 1.6 | 12.5 ± 2.8 | 0.00 |
| VAS of back pain | |||
| Preoperative | 6.1 ± 1.1 | 5.9 ± 1.1 | 0.63 |
| 6 months after operation | 2.9 ± 0.8 | 2.5 ± 0.9 | 0.03 |
| 12 months after operation | 2.0 ± 0.7 | 1.7 ± 0.8 | 0.17 |
| VAS of leg pain | |||
| Preoperative | 6.1 ± 1.0 | 5.8 ± 1.4 | 0.48 |
| 6 months after operation | 2.7 ± 1.01 | 2.3 ± 1.0 | 0.18 |
| 12 months after operation | 1.6 ± 0.7 | 1.2 ± 1.0 | 0.12 |
| SF-36 | |||
| Preoperative | 41.3 ± 3.6 | 43.4 ± 4.8 | 0.06 |
| 6 months after operation | 57.8 ± 2.7 | 58.3 ± 2.0 | 0.44 |
| 12 months after operation | 61.7 ± 2.6 | 62.39 ± 1.8 | 0.32 |
| ODI | |||
| Preoperative | 37.8 ± 1.5 | 38.2 ± 1.9 | 0.35 |
| 6 months after operation | 18.6 ± 1.7 | 19.3 ± 1.6 | 0.14 |
| 12 months after operation | 18.4 ± 1.1 | 18.7 ± 1.1 | 0.33 |
| Complications | |||
| Surgical infection | 0/36 | 2/24 | 0.08 |
| Cerebral fluid leakage | 3/36 | 1/24 | 0.53 |
P < 0.05 versus preoperative.